Breaking News, Collaborations & Alliances

Autolomous and BioCentriq Partner to Transform Operations

Will utilize Autolomous’ autoloMATE solution to accelerate batch delivery, ensuring patients have faster access to cutting-edge cell therapies.

Author Image

By: Charlie Sternberg

Associate Editor

Autolomous, a developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, a clinical-phase Cell Therapy contract development and manufacturing organization (CDMO) that recently completed its latest round of fundraising, have partnered to digitize and accelerate process development and manufacturing activities.   Autolomous’ autoloMATE solution, a no-code, fully cloud-native software platform, will equip BioCentriq with a pivotal tool to enhance efficienc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters